Litcius/Paper detail

Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials

Mohammad Abufaraj, Takehiro Iwata, Shoji Kimura, Anoud Haddad, Hashim Al‐Ani, Lana Abusubaih, Marco Moschini, Alberto Briganti, Pierre I. Karakiewicz, Shahrokh F. Shariat

2020European Urology98 citationsDOI

Topics & Concepts

MedicineProstate cancerInternal medicineAgonistOncologyRandomized controlled trialGonadotropin-releasing hormoneRelative riskMeta-analysisGonadotropin-releasing hormone antagonistAdverse effectConfidence intervalCancerHormoneLuteinizing hormoneReceptorProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentHormonal and reproductive studies
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials | Litcius